The Microbiome: Emerging Opportunities for Biopharma

When: April 18, 2019 - April 19, 2019
Where: Harvard Medical School, 25 Shattuck St, Boston, MA 02115

The near-term opportunities of the microbiome for the biopharma industry are rapidly increasing. This program is designed to help leaders understand the related scientific and strategic implications.

Excitement and investment in the microbiome and its near-term opportunities for the biopharma industry are rapidly increasing. As the microbiome is implicated in progressively more diseases, emerging studies have validated the concept of microbiome-based diagnostics and therapeutics. The accelerating pace of scientific and technologic advances makes it especially challenging for industry leaders to keep up with the latest developments, and understand their scientific and strategic implications. “The Microbiome: Emerging Opportunities for Biopharma” is designed to address this gap.

Learn more »

Connect With Us

Blog Facebook LinkedIn Twitter